Pages that link to "Q43723423"
Jump to navigation
Jump to search
The following pages link to VEGF-initiated blood-retinal barrier breakdown in early diabetes. (Q43723423):
Displaying 50 items.
- VEGF-Trap: a VEGF blocker with potent antitumor effects (Q24535043) (← links)
- New Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic Retinopathy (Q26765468) (← links)
- Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant (Q26775853) (← links)
- Functions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathy (Q26824541) (← links)
- Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes (Q28584295) (← links)
- Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats (Q28730878) (← links)
- Systemic propranolol reduces b-wave amplitude in the ERG and increases IGF-1 receptor phosphorylation in rat retina (Q28854271) (← links)
- The mouse retina as an angiogenesis model (Q30495106) (← links)
- Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization (Q30884052) (← links)
- Clinical trials on corticosteroids for diabetic macular edema (Q31146864) (← links)
- Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes (Q33204824) (← links)
- Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits (Q33335166) (← links)
- Endoplasmic reticulum stress and diabetic retinopathy (Q33352111) (← links)
- Intravitreal bevacizumab for treatment of diabetic macular edema (Q33425236) (← links)
- Intravitreal steroid versus macular laser for treatment of diabetic macular edema (Q33488382) (← links)
- Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy (Q33625491) (← links)
- Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site (Q33696019) (← links)
- Betacellulin Induces Increased Retinal Vascular Permeability in Mice (Q33728352) (← links)
- A Review of Ranibizumab for the Treatment of Diabetic Retinopathy (Q33740152) (← links)
- Vascular endothelial growth factor-A165b ameliorates outer-retinal barrier and vascular dysfunction in the diabetic retina (Q33742338) (← links)
- Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4. (Q33869840) (← links)
- PEDF regulates vascular permeability by a γ-secretase-mediated pathway (Q33939170) (← links)
- Human genetics of diabetic retinopathy: current perspectives (Q34035397) (← links)
- Triple therapy: Phaco-vitrectomy with ILM peeling, retinal endophotocoagulation, and intraoperative use of bevacizumab for diffuse diabetic macular edema. (Q34213181) (← links)
- Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy (Q34356152) (← links)
- Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells (Q34390960) (← links)
- Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes (Q34620720) (← links)
- A three-pore model describes transport properties of bovine retinal endothelial cells in normal and elevated glucose (Q34645639) (← links)
- Critical appraisal of ranibizumab in the treatment of diabetic macular edema (Q34803171) (← links)
- Targeting Neovascularization in Ischemic Retinopathy: Recent Advances (Q34972210) (← links)
- Two polymorphisms (rs699947, rs2010963) in the VEGFA gene and diabetic retinopathy: an updated meta-analysis (Q35019229) (← links)
- Neonatal hyperglycemia inhibits angiogenesis and induces inflammation and neuronal degeneration in the retina (Q35053184) (← links)
- Intravitreal injection of Bevacizumab in diabetic macular edema (Q35061041) (← links)
- Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes (Q35070770) (← links)
- Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury (Q35073329) (← links)
- Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy (Q35102944) (← links)
- Population pharmacokinetics of pegaptanib sodium (Macugen(®)) in patients with diabetic macular edema (Q35111433) (← links)
- Anti-VEGF for the management of diabetic macular edema (Q35151008) (← links)
- The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier Breakdown (Q35195333) (← links)
- Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice. (Q35350451) (← links)
- Diabetic retinopathy - ocular complications of diabetes mellitus (Q35437840) (← links)
- Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier. (Q35575592) (← links)
- Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage (Q35600275) (← links)
- Different expressions of AQP1, AQP4, eNOS, and VEGF proteins in ischemic versus non-ischemic cerebropathy in rats: potential roles of AQP1 and eNOS in hydrocephalic and vasogenic edema formation (Q35663750) (← links)
- Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats (Q35728596) (← links)
- Sugar creates a sticky business: round up the usual suspects (Q35748024) (← links)
- Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor (Q35791512) (← links)
- Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown (Q35791582) (← links)
- Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. (Q35885116) (← links)
- Associations between Retinal Markers of Microvascular Disease and Cognitive Impairment in Newly Diagnosed Type 2 Diabetes Mellitus: A Case Control Study (Q35895087) (← links)